DAIICHI® UNVEILS NEW BRAND IDENTITY REFLECTING

By A Mystery Man Writer

China–Taiwan Weekly Updates Institute for the Study of War

Patritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

The Yearbook cover

Dai-ichi Life: Our approach to human rights as a responsible investor, Case study

Daiichi Sankyo, Inc. Launches CommitmentsinPainCare.com

Fake Lilly Twitter Account Tweets “Insulin Is Free Now,” Temporarily Wiping Billions From Company's Stock Value - 340B Report

Daiichi Sankyo, Head of Data Governance, R&D: Data Governance and Data Management as a Strategic Asset of a Company

Materiality and contribution to the SDGs - Our Approach to Sustanability - Sustainability - Daiichi Sankyo

Passion for innovation. Compassion for patients. - Daiichi Sankyo US